Semaglutide provides powerful protection against diabetic retinopathy, study suggests

GLP-1 receptor agonist drugs protect against diabetic retinopathy, a common complication of diabetes that can lead to sight loss, suggests new research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria (15–19 September) and published in the journal Pharmaceutics.

source https://medicalxpress.com/news/2025-09-semaglutide-powerful-diabetic-retinopathy.html